• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by AirSculpt Technologies Inc.

    11/8/24 8:42:05 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care
    Get the next $AIRS alert in real time by email
    SC 13G/A 1 tm2428004d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

     

    SCHEDULE 13G

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934 

    (AMENDMENT NO. 3)

     

    AIRSCULPT TECHNOLOGIES, INC.
    (Name of Issuer)
     
    Common Stock, $0.001 par value per share
    (Title of Class of Securities)
     
    009496100
    (CUSIP Number)
     
    September 30, 2024
    (Date of Event Which Requires Filing of This Statement)

     

    Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

     

    ¨ Rule 13d-1(b)

    ¨ Rule 13d-1(c)

    x Rule 13d-1(d)

     

    The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

      1   NAME OF REPORTING PERSONS    
          Aaron Rollins    
               
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨
            (b) ¨
               
      3   SEC USE ONLY    
               
      4   CITIZENSHIP OR PLACE OF ORGANIZATION    
          United States    
               
          5   SOLE VOTING POWER
      NUMBER OF       14,712,046(1)
      SHARES   6   SHARED VOTING POWER
      BENEFICIALLY       0
      OWNED BY   7   SOLE DISPOSITIVE POWER
      EACH       14,712,046(1)
      REPORTING   8   SHARED DISPOSITIVE POWER
      PERSON WITH       0
      9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
          14,712,046(1)  
             
      10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ¨
             
      11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9  
          25.28%(2)  
             
      12   TYPE OF REPORTING PERSON*  
          IN  
             

     

    (1) Consists of 14,387,478 shares of Common Stock held directly by Dr. Rollins and 324,568 shares of Common Stock underlying restricted stock units that will vest within 60 days of September 30, 2024.

     

    (2) This percentage is calculated based on 57,882,284 shares of Common Stock outstanding as of November 7, 2024, as set forth in the Issuer’s Quarterly Report on Form 10-Q for the period ended September 30, 2024, filed with the Securities and Exchange Commission on November 8, 2024, and assuming the issuance of 324,568 shares of Common Stock underlying restricted stock units that will vest within 60 days of September 30, 2024 for an aggregate 58,206,852 shares of Common Stock outstanding.

     

     

     

     

    Item 1 (a). Name of Issuer:

     

    AirSculpt Technologies, Inc.

     

    Item 1 (b). Address of Issuer's Principal Executive Offices:

     

    c/o AirSculpt Technologies, Inc.

    1111 Lincoln Road, Suite 802

    Miami Beach, Florida 33139

     

    Item 2 (a). Name of Person Filing:

     

    The person filing this statement is Aaron Rollins.

     

    Item 2 (b). Address of Principal Business Office or, if None, Residence:

     

    c/o AirSculpt Technologies, Inc.

    1111 Lincoln Road, Suite 802

    Miami Beach, Florida 33139

     

    Item 2 (c). Citizenship:

     

    Aaron Rollins is a United States citizen.

     

    Item 2 (d). Title of Class of Securities:

     

    Common Stock, $0.001 par value per share.

     

    Item 2 (e). CUSIP Number:

     

    009496100

     

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

     

    (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3):

     

    (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: __

     

     

     

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

     

    (a) Amount beneficially owned: 14,712,046

     

    (b) Percent of class: 25.28%

     

    (c) Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 14,712,046

     

    (ii) Shared power to vote or to direct the vote: 0

     

    (iii) Sole power to dispose or to direct the disposition of: 14,712,046

     

    (iv) Shared power to dispose or to direct the disposition of: 0

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

     

    N/A

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    N/A

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    N/A

     

    Item 8. Identification and Classification of Members of the Group.

     

    N/A

     

    Item 9. Notice of Dissolution of Group.

     

    N/A

     

    Item 10. Certification.

     

    N/A

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    November 8, 2024

     

      By: /s/ Aaron Rollins
        Aaron Rollins

     

     

     

    Get the next $AIRS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AIRS

    DatePrice TargetRatingAnalyst
    10/17/2024Neutral
    BTIG Research
    5/14/2024$8.25 → $5.00Outperform → Market Perform
    Leerink Partners
    11/11/2022$4.00Overweight → Neutral
    Piper Sandler
    6/16/2022$17.00 → $8.50Overweight → Equal-Weight
    Morgan Stanley
    11/23/2021$18.00Outperform
    Raymond James
    11/23/2021$17.00Overweight
    Morgan Stanley
    11/23/2021$26.00Outperform
    SVB Leerink
    11/23/2021$22.00Overweight
    Piper Sandler
    More analyst ratings

    $AIRS
    Leadership Updates

    Live Leadership Updates

    See more
    • AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer

      MIAMI BEACH, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), an industry leader and provider of premium body contouring procedures, today announced the appointment of Yogi Jashnani as Chief Executive Officer ("CEO") and a member of the Board of Directors. He succeeds Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer who will continue as Chief Financial Officer, all effective January 7, 2025. A highly-talented, results oriented executive with an accomplished career spanning more than two decades, Mr. Jashnani has architected successful transformations for public and private companies in the aesthetics

      12/17/24 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    $AIRS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

      MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2025. "We began the year reporting results in line with our expectations, and while we are early in our transformation, I am encouraged by the progress the team has made on the business imperatives we set in place at the start of the year and I remain confident that we have identified and are implementing the right actions to return to growth," stated Yogi Jashnani, Chief Executive Officer. "To this end, the first quarter saw profitability

      5/2/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2025 financial results before market open on Friday, May 2, 2025, to be followed by a conference call on the same day at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13753206 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirScul

      4/25/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

      MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2024. "Following a challenging 2024, I am eager to help write the next chapter for AirSculpt and focus on setting a strategy, implementing business processes and developing a culture that delivers meaningful value for our shareholders," stated Yogi Jashnani, Chief Executive Officer. "AirSculpt possesses many strengths given its proprietary method, its successful track record of providing more th

      3/14/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    $AIRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by AirSculpt Technologies Inc.

      SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

      11/8/24 8:42:05 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by AirSculpt Technologies Inc. (Amendment)

      SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)

      2/14/24 1:11:48 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AirSculpt Technologies Inc.

      SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)

      4/27/23 9:49:49 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    $AIRS
    Financials

    Live finance-specific insights

    See more

    $AIRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance

      MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2025. "We began the year reporting results in line with our expectations, and while we are early in our transformation, I am encouraged by the progress the team has made on the business imperatives we set in place at the start of the year and I remain confident that we have identified and are implementing the right actions to return to growth," stated Yogi Jashnani, Chief Executive Officer. "To this end, the first quarter saw profitability

      5/2/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call

      MIAMI BEACH, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report first quarter 2025 financial results before market open on Friday, May 2, 2025, to be followed by a conference call on the same day at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13753206 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirScul

      4/25/25 6:45:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

      MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2024. "Following a challenging 2024, I am eager to help write the next chapter for AirSculpt and focus on setting a strategy, implementing business processes and developing a culture that delivers meaningful value for our shareholders," stated Yogi Jashnani, Chief Executive Officer. "AirSculpt possesses many strengths given its proprietary method, its successful track record of providing more th

      3/14/25 6:00:00 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/20/25 4:11:19 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Jashnani Yogesh bought $18,532 worth of shares (7,000 units at $2.65), increasing direct ownership by 2% to 464,879 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/7/25 5:56:15 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    $AIRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chairman Rollins Aaron bought $7,629 worth of shares (2,118 units at $3.60), increasing direct ownership by 0.01% to 15,146,039 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/20/25 4:11:19 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Director Chu Caroline was granted 58,594 shares, increasing direct ownership by 50% to 176,780 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/8/25 7:55:44 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • Director Aaron Thomas J was granted 58,594 shares, increasing direct ownership by 50% to 176,580 units (SEC Form 4)

      4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

      5/8/25 7:54:38 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care

    $AIRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $AIRS
    SEC Filings

    See more
    • BTIG Research initiated coverage on AirSculpt Technologies

      BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral

      10/17/24 7:13:51 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously

      5/14/24 7:53:44 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00

      11/11/22 3:44:11 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      5/8/25 1:47:52 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by AirSculpt Technologies Inc.

      10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)

      5/2/25 3:16:25 PM ET
      $AIRS
      Medical/Nursing Services
      Health Care
    • AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)

      5/2/25 6:01:26 AM ET
      $AIRS
      Medical/Nursing Services
      Health Care